Fulcrum Therapeutics Inc. (FULC)
NASDAQ: FULC
· Real-Time Price · USD
7.27
-0.39 (-5.09%)
At close: Sep 08, 2025, 3:59 PM
7.20
-0.96%
After-hours: Sep 08, 2025, 07:30 PM EDT
Fulcrum Therapeutics Revenue
Fulcrum Therapeutics reported an annual revenue of $80M, reflecting a 2752.05% growth. For the quarter ending June 30, 2025, Fulcrum Therapeutics generated $0 in revenue.
Revenue (ttm)
80M
Revenue Growth
2752.05%
Price / Sales Ratio
3.64
Revenue / Employee
1.78M
Employees
45
Market Cap
393.25M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2024 | 80M | +2752.05% |
| Dec 31, 2023 | 2.81M | -55.77% |
| Dec 31, 2022 | 6.34M | -66.90% |
| Dec 31, 2021 | 19.16M | +117.19% |
| Dec 31, 2020 | 8.82M | +Infinity% |
| Dec 31, 2019 | 0 | n/a |
| Dec 31, 2018 | 0 | n/a |
| Dec 31, 2017 | 0 | n/a |